Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Shinkai

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Respiratory system]Yuka Katou, Tetsu Shinkai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[Intrapleural chemotherapy--current status and problems in Japan]Atsuko Ogino, Tetsu Shinkai
Pathology International|June 4, 2009
Re-classification of pTNM staging for lung cancer: single-institution report at a Japanese comprehensive cancer hospitalNorihiro Teramoto, Rieko Nishimura, Hiroyuki Takahata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 13, 2009
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examinationShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.
Japanese Journal of Radiology|February 8, 2012
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapyYasushi Hamamoto, Masaaki Kataoka, Naoyuki Nogami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment]Shigeki Sawada, Motohiro Yamashita, Eisaku Komori, et al.
Internal Medicine (Tokyo, Japan)|February 26, 2019
Portal Vein Thrombosis in a Patient with Hereditary Antithrombin DeficiencyTamao Setaka, Katsuharu Hirano, Keiichi Moriya, et al.
Chest|September 16, 2005
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical conditionShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.
Investigational New Drugs|August 18, 2020
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913Yoshiro Nakahara, Tsuneo Shimokawa, Yuki Misumi, et al.
BMC Cancer|August 19, 2011
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01)Masaaki Kawahara, Harue Tada, Akihiro Tokoro, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Respiratory system]Yuka Katou, Tetsu Shinkai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[Intrapleural chemotherapy--current status and problems in Japan]Atsuko Ogino, Tetsu Shinkai
Pathology International|June 4, 2009
Re-classification of pTNM staging for lung cancer: single-institution report at a Japanese comprehensive cancer hospitalNorihiro Teramoto, Rieko Nishimura, Hiroyuki Takahata, et al.
Lung Cancer (Amsterdam, Netherlands)|January 13, 2009
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examinationShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.
Japanese Journal of Radiology|February 8, 2012
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapyYasushi Hamamoto, Masaaki Kataoka, Naoyuki Nogami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment]Shigeki Sawada, Motohiro Yamashita, Eisaku Komori, et al.
Internal Medicine (Tokyo, Japan)|February 26, 2019
Portal Vein Thrombosis in a Patient with Hereditary Antithrombin DeficiencyTamao Setaka, Katsuharu Hirano, Keiichi Moriya, et al.
Chest|September 16, 2005
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical conditionShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.
Investigational New Drugs|August 18, 2020
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913Yoshiro Nakahara, Tsuneo Shimokawa, Yuki Misumi, et al.
BMC Cancer|August 19, 2011
Quality-of-life evaluation for advanced non-small-cell lung cancer: a comparison between vinorelbine plus gemcitabine followed by docetaxel versus paclitaxel plus carboplatin regimens in a randomized trial: Japan Multinational Trial Organization LC00-03 (BRI LC03-01)Masaaki Kawahara, Harue Tada, Akihiro Tokoro, et al.
Pageof 5